Tuesday, April 23, 2024
Home Biotech News Exsosomes

Exsosomes

    Random

    Heads Up! Big News on Stem Cells & Covid This Weekend.

    Stem Cells Editor / Curator -
    Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
    Organicell

    Organicell (BPSR) a Triple Since Easter.

    Infections Editor / Curator -
    Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...
    Biotech Stock Review, Exsosomes

    Exosomes, Extracellular Vesicles, and the CoronaVirus.

    Biotech News Editor / Curator -
    Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1:...
    Organicell

    Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

    Superbug News - CoronaVirus Watch List Editor / Curator -
    Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...

    Latest article

    Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

    All News Editor / Curator -
    Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

    Major Mpox Outbreak in the Democratic Republic of Congo.

    Mpox Editor / Curator -
    As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

    Mpox Infections Rise to Almost Double Last Year’s Numbers.

    All News Editor / Curator -
    The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.